glp 1 hba1c reduction and body weight related to the use of GLP-1 RAs in Newer Glucagon-Like Peptide-1 Receptor Agonists

It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake

44 The actions of GIP in vascular endothelial cells are notable for enhancing the intracellular calcium levels and nitric oxide without affecting endothelin-1 production

Danuglipron made it further to Phase IIb, but Pfizer ended the entire program in April 2025 after a single asymptomatic case of potential drug-induced liver injury and dropped its third oral candidate a few months later

Results and experiences from the Shaklee 180 Program are unique for each person, so results may vary